- Projects & figures
- News & Events
- Managing your project
- About ERC
One of the biggest drawbacks of electric vehicles – that they require hours and hours to charge – could be obliterated by a new type of liquid battery that is roughly ten times more energy-dense than existing models, according to Professor Lee Cronin, the Regius Chair of Chemistry at the University of Glasgow, UK.
Originally from Gijón (Spain), Prof. Eva Hevia is Professor of Inorganic Chemistry at the University of Strathclyde, in Glasgow (UK). First an Erasmus student, then a recipient of both Marie Skłodowska-Curie and ERC grants, she believes that each of these three EU funding schemes has represented a milestone at different stages of her career and has paved the future of her research.
ERC grantee Alvaro Mata, from Queen Mary’s School of Engineering and Materials Science, has developed a new way to grow mineralised materials which could regenerate hard tissues such as dental enamel and bone. The findings are reported today in Nature Communications.
“The internet of things” is said to be the next big frontier for technology firms. A variety of small devices are always on and always connected. These devices permeate our lives at an ever increasing rate, bringing with them a demand for new and innovative mobile energy sources. One of the most promising candidates is thermoelectric power; a technology that would allow us to harvest one of the most ubiquitous energy sources available to us, our body heat.
Ben Feringa is a Professor in Organic Chemistry at the University of Groningen and the pioneer of rotary molecular motors, the smallest machines in the world of the size of individual molecules.
In 2016, Prof Feringa was awarded the Nobel Prize in Chemistry for his work on synthetic chemistry, leading to the design and synthesis of novel molecules and nanomaterials, with machine-like functions. These molecular nanomachines can respond to stimuli from their environment, be employed in the self-assembly of nanostructures or regulate DNA transcription, with potential applications in the medical field and targeted treatments.
Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."
Faster, greener and more sustainable: our world is thirsty for innovative processes that meet these demanding criteria. While natural resources can offer part of the solution, the biggest challenge lies in cleaning-up chemical synthesis. Prof. Georgios Vasilikogiannakis and his team have been looking for answers.
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T lymphocytes, identify, target and attack liver cells that are infected with the hepatitis B virus. To witness these immune cells in action in real time, the two scientists developed advanced, dynamic imaging techniques. An estimated 240 million people are chronically infected with hepatitis B worldwide. This discovery, published today in the scientific journal Cell, opens new horizons for the development of novel therapies.
At the École Polytechnique Fédérale de Lausanne (EPFL) in Switzerland, Professor Anna Fontcuberta i Morral’s ERC-funded UPCON project (Ultra-pure nanowire heterostructures and energy conversion) is investigating new concepts and technologies that point the way to the next generation of photovoltaic systems. Prof Fontcuberta i Morral is a speaker at this year's American Association for the Advancement of Science (AAAS) conference in Chicago, where she will give a talk entitled 'Nanowires have the power to revolutionize solar energy'.
Have you ever seen an engineer conducting an imaginary orchestra? We think of scientists working in a lab, but Professor Tapio Lokki, of the Aalto University School of Science in Finland, has spent the last few years visiting concert halls and making meticulous measurements of their characteristics. ‘Karaoke’ is Japanese for ‘empty orchestra’ – and in some ways that is what he has created to help his studies. The research could lead to improved building designs and a form of audio ‘Augmented Reality’ (AR).
Vaccination has achieved huge success in controlling many devastating infectious diseases. However, there are still many such diseases, or ‘pathogens’, against which we cannot generate life-long protective immunity. On the eve of Croatia’s accession to the EU, Professor Stipan Jonjic’s ERC-funded research into new vaccines to offer better protection– is already underway. Prof Jonjic is the first Croatian ERC grantee to base his project in Croatia.